Featured News
617Wire StoriesGlobal E-Pharmacy Market Size & Share to 2027 – Featuring Pharmacy2U, Gordons Direct and MedPlus Health Services Among Others – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global E-Pharmacy Market Size & Share to 2027” report has been added to ResearchAndMarkets.com’s offering. E-pharmacy is referred as electronic...
- 560Wire Stories
AM Best Affirms Credit Ratings of Dhipaya Insurance Public Company Limited
SINGAPORE–(BUSINESS WIRE)–AM Best has affirmed the Financial Strength Rating of A- (Excellent) and the Long-Term Issuer Credit Rating of “a-” (Excellent) of...
- 772Wire Stories
Hytera at CCW 2022 Is Showcasing Convergence-Native Solutions for Critical Communications Sector
VIENNA–(BUSINESS WIRE)–#5G–Critical Communications Week (CCW) took place in Vienna, Austria on 21st June, 2022. The event has been running for over twenty...
- 612News
Best Mart 360 Holdings Limited Announces FY2021/22 Annual Results; Core Net profit Surged Significantly by 121.0% YoY; Proposed a final dividend of HK$8.0 cents per share
Highlights: Revenue increased by 21.8% to approximately HK$1,983.5million. Gross profit increased by 28.4% to approximately HK$667.7 million. Operating profit increased by 39.2%...
- 1.4KWire Stories
Kyowa Kirin Receives Positive CHMP Opinion for Use of CRYSVITA® ?(burosumab) for the Treatment of Tumour-Induced Osteomalacia (TIO)
CRYSVITA could offer access to the first biologic treatment for EU patients with TIO who cannot undergo surgical removal of tumours TOKYO–(BUSINESS...
- 626Wire Stories
Dr. Reddy’s Laboratories Announces the Acquisition of an Injectable Product Portfolio from Eton Pharma
HYDERABAD, India & PRINCETON, N.J.–(BUSINESS WIRE)–$RDY #Acquisition–Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries...
- 517Wire Stories
Locix’s Warehouse Intelligence Solution Deployment Named a Recipient of Supply & Demand Chain Executive’s Top Supply Chain Projects Awards
This award spotlights successful and innovative transformation projects that deliver bottom-line value to small, medium, and large enterprises across a range of...
- 556Wire Stories
Propanc Biopharma Announces No Immediate Plans for Reverse Stock Split
Company Filed a Definitive Information Statement Under Section 14C of the Exchange Act MELBOURNE, Australia–(BUSINESS WIRE)–Propanc Biopharma, Inc. (OTCQB: PPCB) (“Propanc” or...
- 625Wire Stories
Entegris and CMC Materials Receive China Antitrust Clearance for Pending Acquisition
Transaction Expected to Close on July 6, 2022 BILLERICA, Mass. & AURORA, Ill.–(BUSINESS WIRE)–Entegris, Inc. (NASDAQ: ENTG) and CMC Materials, Inc. (NASDAQ:...
- 572Wire Stories
Growing Number of CAGR of 4.3% from 2022 to 2030, mTOR Inhibitors Market Size to USD 9,445 Mn by 2030 Report By Acumen Research and Consulting
Acumen Research and Consulting recently published report titled “mTOR Inhibitors Market Size, Share, Analysis Report and Region Forecast, 2022 – 2030” LOS...
- 523Wire Stories
Biolexis and Akston Biosciences Announce Encouraging Top-Line Results from Phase II/III Trial of their Thermostable 2nd Gen COVID-19 Vaccine
Results of 100 subjects bridging study and 1,500 subjects placebo-controlled trial of Akston’s AKS-452 announced. Interim analysis shows a 91% seroconversion rate....
